Radiopharm Theranostics Limited (AU:RAD) has released an update.
Radiopharm Theranostics Limited has announced a new securities issuance that includes several options expiring in 2025 and 2026, along with a substantial number of ordinary shares, set to be proposed on August 8, 2024. The company is preparing to offer these securities under a disclosure document or Product Disclosure Statement (PDS), with the intent of having them quoted on the ASX. This strategic move aims to bolster the company’s financial position and fuel its growth initiatives.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.
